Navigation Links
American Scientific Resources Will be a Presenter at the Undiscovered Equities Spring Conference in Boca Raton
Date:6/6/2011

WESTON, Fla., June 6, 2011 /PRNewswire/ -- American Scientific Resources, Incorporated (OTCQB: ASFX) (the "Company") will be presenting at the Undiscovered Equities Spring Conference held in Boca Raton, Florida on Wednesday, June 8, 2011 at Ruth's Chris Steak House, 999 East Camino Real, Boca Raton, FL  33432. The Company will be presenting in the afternoon time slots during the all day conference.

(Logo: http://photos.prnewswire.com/prnh/20110124/NY34439LOGO)

Dr. Christopher F. Tirotta, CEO and Chairman of the Board, will discuss the Company's ongoing developments regarding its two proprietary products, the VeraTemp Non-Contact thermometer line and the Disintegrator needle destruction device.

"I am very much looking forward to participating in the Undiscovered Equities Spring Conference and educating the attendees on the promising developments of late, including the expansion of the VeraTemp's domestic retailers and international distribution," stated Dr. Tirotta.

The Kidz-Med VeraTemp Non Contact Thermometer is a non-contact thermometer that, by using safe infrared technology aimed at the patient's forehead, measures body temperature instantly without contacting the patient's skin. The VeraTemp is FDA approved, and clinical testing has demonstrated it is as accurate as oral, rectal or ear thermometers. Not only does non-contact mean convenience and trouble-free measurement when reading body temperature, it also allows you to measure babies' bottle, food, bath water and room temperature.

About American Scientific Resources, Incorporated

American Scientific Resources, Inc. (the "Company") manufactures consumer products for use in the clinical, home healthcare, infant and juvenile product businesses. The Company designs new health and safety products, develops technology and intellectual property, and distributes the manufactured products through relationships formed by our management and channels obtained through the Company's network of global healthcare distributors and retailers. The Company's products include the brands Kidz-Med®, VeraTemp® and the Disintegrator®. The Kidz-Med brand focuses on early childhood development, the VeraTemp+ Non-Contact Thermometer is designed for emergency services, long term care and school/university use, and the Disintegrator focuses on providing a global solution for patients requiring specialty injection drugs to safely and legally dispose of their sharps. For more information about the Company, please contact our Investor Relations department via e-mail at IR@americansci.com or by phone at (561) 948-4863.

For more information, visit the corporate web site at www.americansci.com, www.kidzmed.com

and www.disintegratorplus.com

Forward Looking Statements

The information contained herein includes forward-looking statements. When used in this press release, the words "will," "future," "expect," "look forward to," similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward- looking statements.    These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. A detailed discussion of these factors and other risks that affect our business is contained in our filings with the Securities and Exchange Commission, including our most recent report on Form 10-K, particularly under the heading "Risk Factors." We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, unless required by applicable law. All information set forth in this press release is current as of June 6, 2011.

For more information, contact: Investor Relations
American Scientific Resources
IR@americansci.com
561-948-4863
4852-0520-3721, v. 2


'/>"/>
SOURCE American Scientific Resources, Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
2. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
3. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
4. American Scientific Resources, Inc. Announces Dismissal of Sanomedics International Holdings, Inc. lawsuit
5. American Scientific Resources, Inc. Announces Quarterly Results
6. Omron Healthcare Announces Donation to the American Society of Hypertension, Inc.
7. American Regent Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter
8. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting
10. Dendreon Announces Presentation of PROVENGE Data at the 2011 American Society of Clinical Oncology Annual Meeting
11. ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):